NCT07637396

Brief Summary

The goal of this observational study or clinical trial is to investigate how exercise can affect different areas of a person's life, especially those people with vascular disease. This is important because exercise can be beneficial for people with vascular disease. The study could include any of the following: those aged 65 years of age and older, between the ages of 50-64 who smokes, has diabetes, high blood pressure, high cholesterol, or has a family member with vascular disease, between the ages of 18-49 with diabetes and one other factor listed above, or those with vascular disease. The main question\[s\] it aims to answer is if exercise testing can better predict vascular disease. The following research questions will be addressed in this study:

  • complete various questionnaires and a routine screening for vascular disease \*walk for 6 minutes at your own pace
  • additional vascular screening tests will be performed.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
17mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jun 2026Jan 2028

First Submitted

Initial submission to the registry

May 26, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 9, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

June 9, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 26, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

peripheral arterial diseaseankle brachial indexdoppler ultrasound

Outcome Measures

Primary Outcomes (1)

  • magnitude of ABI reduction

    Measured as both absolute and percent change, calculated as the difference between baseline ABI and ABI immediately after exercise, at 1-, 3-, and 5-minute recovery intervals.

    immediately after exercise, at 1-, 3-, and 5-minute recovery intervals.

Secondary Outcomes (8)

  • Short-Form 36 (SF-36)

    prior to baseline ABI testing

  • International Physical Activity Questionnaire (IPAQ)

    3 times including at rest prior to 6MWT, at minute 3 and again at minute 6 during 6MWT

  • Gait speed

    gait speed between minute 0-1, minute 3-4, and minute 5-6 of 6MWT

  • Time to first standing rest break

    1time during 6MWT

  • Total duration of all standing rest breaks

    1 time during 6MWT

  • +3 more secondary outcomes

Study Arms (1)

study participants

baseline ABI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

recruited from local outpatient rehabilitation, vascular, and internal medicine clinics

You may qualify if:

  • individuals over 65 years of age
  • individuals aged 50-64 with a risk factor for atherosclerosis including diabetes mellitus, history of smoking, hyperlipidemia, hypertension, or family history of peripheral arterial disease (PAD)
  • individuals aged 18-50 with diabetes mellitus and one additional risk factor for atherosclerosis as noted above, or
  • individuals with known atherosclerotic disease in another vascular bed including the coronary, carotid, subclavian, renal, or mesenteric artery stenosis, and individuals with known PAD

You may not qualify if:

  • contraindications to brachial and/or ankle pressure measurement including history of deep vein thrombosis
  • lymphedema of the arms or legs
  • history of mastectomy or current leg ulceration preventing placement of a blood pressure cuff around the lower leg
  • an inability to lie in a supine position for 15 min
  • self-reported inability to walk for 6 minutes
  • severe cardiac or pulmonary disease limiting exercise
  • inability to obtain a Dopplerable pulse
  • noncompressible arteries (ABI \>1.4)
  • those unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LSU Health Shreveport

Shreveport, Louisiana, 71130, United States

Location

Related Publications (5)

  • Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn WR, Goldberg AP. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc. 2001 Jun;49(6):755-62. doi: 10.1046/j.1532-5415.2001.49152.x.

    PMID: 11454114BACKGROUND
  • Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Mar 21;135(12):e686-e725. doi: 10.1161/CIR.0000000000000470. Epub 2016 Nov 13.

    PMID: 27840332BACKGROUND
  • Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Mar 21;135(12):e726-e779. doi: 10.1161/CIR.0000000000000471. Epub 2016 Nov 13.

    PMID: 27840333BACKGROUND
  • McDermott MM, Tian L, Liu K, Guralnik JM, Ferrucci L, Tan J, Pearce WH, Schneider JR, Criqui MH. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol. 2008 Apr 15;51(15):1482-9. doi: 10.1016/j.jacc.2007.12.034.

    PMID: 18402904BACKGROUND
  • Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 2015 Feb;45(2):231-44. doi: 10.1007/s40279-014-0261-z.

    PMID: 25230780BACKGROUND

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Central Study Contacts

Sarah Murnane, PT, DPT, PhD(c)

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 9, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

June 9, 2026

Record last verified: 2026-05

Locations